source
- Sanofi requests removal of teplizumab from FDA fast-track voucher program after director disputeSanofi has formally asked the Food and Drug Administration to withdraw its type 1 diabetes therapy, teplizumab, from the new speedy review voucher program overseen by Commissioner Marty Makary. Th…
- Color Health expands into cancer treatment coordination with virtual tumor boardsColor Health, a telehealth firm that currently coordinates cancer screening, is moving into providing and coordinating actual cancer care services. CEO Othman Laraki says the growing complexity of…